Acadia appoints Adora Ndu to board, increases size to nine directors

ACADIA PHARMACEUTICALS INC

Board increased from 8 to 9 members; Adora Ndu, Pharm.D., J.D. appointed effective Oct 12, 2022.
Dr. Ndu serves as Class I director with term expiring at 2023 Annual Meeting.
Receives standard director compensation: stock option and RSU award each with $150,000 fair value.
Will not initially serve on any board committees.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Adora Ndu

Director

ACAD · ACADIA PHARMACEUTICALS INC

Effective: 2022-10-12
Filed: October 13, 2022, 7:59 PM ET

appointed Adora Ndu, Pharm.D., J.D. as a director to fill the newly created vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adora Ndu was appointed as Director at ACADIA PHARMACEUTICALS INC.

Action: appointed
Role: Director

Exact text from the filing

appointed Adora Ndu, Pharm.D., J.D. as a director to fill the newly created vacancy.

View on SEC.gov

ACADIA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001193125-22-262140

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.